TCM
Tekla Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.27M | Sell |
22,571
-32,509
| -59% | -$1.83M | 0.05% | 125 |
|
|
2023
Q1 | $2.49M | Hold |
55,080
| – | – | 0.09% | 113 |
|
|
2022
Q4 | $2.24M | Hold |
55,080
| – | – | 0.08% | 109 |
|
|
2022
Q3 | $3.6M | Hold |
55,080
| – | – | 0.15% | 94 |
|
|
2022
Q2 | $3.35M | Hold |
55,080
| – | – | 0.13% | 99 |
|
|
2022
Q1 | $3.46M | Hold |
55,080
| – | – | 0.12% | 105 |
|
|
2021
Q4 | $4.17M | Sell |
55,080
-107,257
| -66% | -$8.13M | 0.13% | 106 |
|
|
2021
Q3 | $18.2M | Hold |
162,337
| – | – | 0.59% | 50 |
|
|
2021
Q2 | $26.3M | Buy |
162,337
+11,379
| +8% | +$1.84M | 0.85% | 28 |
|
|
2021
Q1 | $18.4M | Buy |
150,958
+74,736
| +98% | +$9.11M | 0.63% | 42 |
|
|
2020
Q4 | $11.7M | Hold |
76,222
| – | – | 0.41% | 71 |
|
|
2020
Q3 | $6.38M | Hold |
76,222
| – | – | 0.24% | 93 |
|
|
2020
Q2 | $5.6M | Hold |
76,222
| – | – | 0.21% | 94 |
|
|
2020
Q1 | $3.23M | Hold |
76,222
| – | – | 0.15% | 110 |
|
|
2019
Q4 | $4.64M | Sell |
76,222
-25,114
| -25% | -$1.53M | 0.18% | 109 |
|
|
2019
Q3 | $4.15M | Sell |
101,336
-77,012
| -43% | -$3.16M | 0.18% | 94 |
|
|
2019
Q2 | $8.4M | Hold |
178,348
| – | – | 0.34% | 67 |
|
|
2019
Q1 | $6.37M | Hold |
178,348
| – | – | 0.26% | 81 |
|
|
2018
Q4 | $5.1M | Hold |
178,348
| – | – | 0.22% | 86 |
|
|
2018
Q3 | $7.91M | Hold |
178,348
| – | – | 0.29% | 76 |
|
|
2018
Q2 | $10.5M | Buy |
178,348
+37,157
| +26% | +$2.18M | 0.4% | 58 |
|
|
2018
Q1 | $6.45M | Buy |
+141,191
| New | +$6.45M | 0.25% | 84 |
|